Dr Lal PathLabs Competitors and Similar CompaniesClear all
Dr Lal PathLabs's competitors and similar companies include Chinook Therapeutics and Mesoblast.
 Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests. |  Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. |  Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | |
Founding Date | Founding Date 1949 | Founding Date 2011 | Founding Date 2004 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Gurugram, IN HQ | Locations Seattle, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US |
Employees | Employees 4,099 | Employees 27 | Employees 73 |
Financial | |||
Revenue (est.) | Revenue (est.) ₹27.6b (FY, 2026) | Revenue (est.) $6.1m (FY, 2022) | Revenue (est.) $17.2m (FY, 2025) |
Cost of goods | Cost of goods ₹5.3b (FY, 2026) | Cost of goods N/A | Cost of goods $1.2m (FY, 2025) |
Gross profit | Gross profit ₹23.3b (FY, 2026) | Gross profit N/A | Gross profit $16.1m (FY, 2025) |
Net income | Net income ₹5.1b (FY, 2026) | Net income ($187.9m) (FY, 2022) | Net income ($102.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 171m | Total funding raised $ 56.2m |
For sources of this data, please see the company profile
View Company Profiles
Chinook Therapeutics
HQ
Seattle, US
Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View companyMesoblast
HQ
Melbourne, AU
Employees
73
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company